A carregar...

Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations

OBJECTIVE: To evaluate the benefit–risk profile (BRP) of oxycodone/naloxone (OXN) and tapentadol (TAP) in patients with chronic low back pain (cLBP) with a neuropathic component (NC) in routine clinical practice. METHODS: This was a blinded end point analysis of randomly selected 12-week routine/ope...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pain Res
Main Authors: Ueberall, Michael A, Mueller-Schwefe, Gerhard H H
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115682/
https://ncbi.nlm.nih.gov/pubmed/27881925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S112418
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!